Division of General Academic Pediatrics, MassGeneral Hospital for Children, the Department of Pediatrics and the Section of General Internal Medicine, Boston Medical Center, and the Massachusetts Department of Public Health, Boston, Massachusetts; the Department of Obstetrics and Gynecology, Virginia Commonwealth University, Richmond, Virginia; and the Division of Child and Adolescent Psychiatry, Massachusetts General Hospital, Boston, and the Division of Preventive and Behavioral Medicine and Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
Corresponding author: Davida M. Schiff, MD, MSc, 125 Nashua Street, Boston, MA 02114; email: [email protected].
Dr. Schiff was supported by HRSA T32HP10028; Dr. Larochelle was supported by NIDA (K23 DA042168) and a Boston University School of Medicine Department of Medicine Career Investment Award; Mr. Nielsen was supported by the Applied Epidemiology Fellowship Program administered by the Council of State and Territorial Epidemiologists and funded by the Centers for Disease Control and Prevention Cooperative Agreement Number 1U38OT000143-04.
Presented at the Massachusetts Perinatal Quality Collaborative Meeting: Improving the Care of Opioid-Exposed Newborns and their Families, September 27, 2017, Framingham, Massachusetts.
Financial Disclosure The authors did not report any potential conflicts of interest.
The authors thank the Massachusetts Department of Public Health for creating the unique, cross-sector database used for this project and for providing technical support for the analysis; Drs. Susan Manning and Nick Somerville who provided feedback on the project design; and Drs. Elsie Taveras, Mardge Cohen, and Simeon Kimmel for their critical reviews of an earlier version of the manuscript.
Each author has indicated that he or she has met the journal's requirements for authorship.
Received February 15, 2018. Received in revised form April 13, 2018. Accepted April 26, 2018.
